229 related articles for article (PubMed ID: 6449903)
1. Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.
Robinson RG; Saunders J; Cassel R; Block CS; Koornhof HJ
Antimicrob Agents Chemother; 1980 Oct; 18(4):493-501. PubMed ID: 6449903
[TBL] [Abstract][Full Text] [Related]
2. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.
Fu KP; Neu HC
Antimicrob Agents Chemother; 1978 Mar; 13(3):358-67. PubMed ID: 122519
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies of piperacilin, a new semisynthetic penicillin.
Winston DJ; Wang D; Young LS; Martin WJ; Hewitt WL
Antimicrob Agents Chemother; 1978 Jun; 13(6):944-50. PubMed ID: 677861
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
Jones RN; Packer RR; Barry AL; Badal RE; Thornsberry C; Baker C
J Antibiot (Tokyo); 1979 Jan; 32(1):29-35. PubMed ID: 761991
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
George WL; Lewis RP; Meyer RD
Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.
Lyon MD; Smith KR; Saag MS; Cloud GA; Cobbs CG
Antimicrob Agents Chemother; 1986 Jul; 30(1):25-30. PubMed ID: 3092731
[TBL] [Abstract][Full Text] [Related]
7. Netilmicin: its in vitro activity and synergism with penicillin compounds.
Thadepalli H; Roy I
Chemotherapy; 1980; 26(1):12-20. PubMed ID: 7353438
[TBL] [Abstract][Full Text] [Related]
8. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Reimer LG; Mirrett S; Reller LB
Antimicrob Agents Chemother; 1980 Mar; 17(3):412-6. PubMed ID: 6448577
[TBL] [Abstract][Full Text] [Related]
10. Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin.
Machka K; Baierl W; Braveny I
Eur J Clin Microbiol; 1982 Aug; 1(4):238-42. PubMed ID: 6217066
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.
Wise R; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1978 Oct; 14(4):549-52. PubMed ID: 102245
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
Shah PP; Briedis DJ; Robson HG; Conterato JP
Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
[TBL] [Abstract][Full Text] [Related]
13. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
Schassan HH; Koperski K; Scherf H
Chemotherapy; 1978; 24(3):134-42. PubMed ID: 95925
[TBL] [Abstract][Full Text] [Related]
14. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
Hoogkamp-Korstanje JA; Westerdaal NA
Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
Fass RJ; Prior RB
Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB
Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274
[TBL] [Abstract][Full Text] [Related]
17. Combination effect of piperacillin with four aminoglycosides on nonfermenting gram-negative bacteria.
Daschner F; Langmaack H; Grehn M; Steffens A; Just M
Chemotherapy; 1981; 27(1):39-43. PubMed ID: 6452252
[TBL] [Abstract][Full Text] [Related]
18. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
Watanakunakorn C
J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
[TBL] [Abstract][Full Text] [Related]
19. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
20. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]